Cat. No. | Species | Product Description | Structure | Purity | Feature |
---|---|---|---|---|---|
HM1-M52H6 | Mouse | Mouse HMGB1 Protein, His Tag |
|
||
HM1-H5255 | Human | Human HMGB1 Protein, Mouse IgG2a Fc Tag, low endotoxin |
|
|
|
HM1-H5220 | Human | Human HMGB1 Protein, His Tag |
|
|
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
Dociparstat sodium | ODSH; CX-01; PGX-100; PGX-ODSH-2013-AML-1 | Phase 1 Clinical | Paringenix | Coronavirus Disease 2019 (COVID-19); Pancreatic Neoplasms; Myelodysplastic Syndromes; Protein-Losing Enteropathies; Pulmonary Disease, Chronic Obstructive; Leukemia, Myeloid, Acute; Acute Lung Injury | Details |
SB-17170 | SB-17170 | Phase 1 Clinical | Spark Biopharma Inc | Solid tumours | Details |
This web search service is supported by Google Inc.